texas oncology more breakthroughs. more victories
I am a: Patient | Caregiver | Refering Physician
Some of our cancer centers may have important notifications found on the location page. View More Important Notifications x

Preethi John, M.D.

Preethi John, M.D. Photo

Provider Type: Physician

Specialties:
Board Certifications:
  • Internal Medicine
  • Medical Oncology
Spoken Language: English

Downloads

General Summary

Dr John is a board-certified medical oncologist specializing in breast cancer. She works with her patients and their multidisciplinary care team to develop an evidence-based treatment plan that aligns with their unique goals and values. She empowers her patients by educating them about their condition so they can make informed decisions regarding their care. Access to advanced therapies are available through participation in clinical trials at Texas Oncology and the US Oncology/Sarah Cannon Research Institute.

Dr John believes in partnering with her patients through their cancer journey with compassion, expertise, and a commitment to their well-being.

Education

  • Fellowship in Hematology-Oncology
    Tufts Medical Center, Boston, MA
  • Residency in Internal Medicine
    Tufts Medical Center, Boston, MA
  • Medical Doctorate
    Drexel University, Philadelphia, PA

Accolades & Memberships

  • American Society of Clinical Oncology
  • American College of Physicians
  • Excellence in Teaching Award for Housestaff/Fellows
  • Komen Foundation Health Disparities Grant Award by ASCO
  • Magna Cum Laude
  • Moore/Moreau Breast Cancer Research Funding Award
  • Sarah Cannon Research Institute Breast Cancer Committee

Clinical Trials

View All Clinical Trials

Publications

  • Comparative Effectiveness of Adjuvant Chemotherapy in Early-Stage Breast Cancer: A Network Meta-analysis

    Clinical breast cancer, 2021

  • A quality improvement initiative to increase screening for financial coverage for breast cancer patients to decrease financial toxicity.

    ASCO Quality Care Symposium, 2021

  • Cost-effectiveness of adjuvant chemotherapy in early-stage breast cancer.

    Journal of Clinical Oncology, 2018

  • Network meta-analysis of adjuvant chemotherapy in early breast cancer

    Journal of Clinical Oncology, 2017

  • Congestive heart failure secondary to gemcitabine nab-paclitaxel in patients with pancreatic cancer

    Anticancer research 34.12, 2014

Show all Publications
  • Radioembolization in the Treatment of Neuroendocrine Tumors of the Pancreas

    JOP. Journal of the Pancreas 15.4, 2014

  • Updates in management of ampullary carcinomas

    Journal of the Pancreas 15.2, 2014

  • When parents disclose BRCA1/2 test results: their communication and perceptions of offspring response

    Cancer 118.13, 2012

Latest News

Community Service

  • Southwestern Christian Fellowship/Christian Medical and Dental Associations, COVID Q&A for Women in the Vickery Meadow Community, TX (2021)
  • Southwestern Christian Fellowship/Christian Medical and Dental Associations, Mentor for Medical Students, TX (2020)
  • Summer Medical Institute, Volunteer, Harlingen, TX (2009)

Research Interest

Dr. John has a clinical and research interest in breast oncology, health care disparities, and clinical trial enrollment.

Medical Practice

  • Clinical Assistant Professor of Medical Education – Department of Internal Medicine, Texas A&M School of Medicine (July 2023 – current)
  • Breast Medical Oncology Faculty Member – Department of Hematology/Oncology, Baylor University Medical Center, Dallas, TX (February 2022 – current)
  • Assistant Professor of Internal Medicine - Division of Hematology/Oncology, UT Southwestern Medical Center, Dallas, TX (August 2019 – January 2022)